Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis

被引:268
|
作者
Choi, Sung R. [1 ]
Howell, Owain W. [1 ,2 ]
Carassiti, Daniele [1 ]
Magliozzi, Roberta [1 ,3 ]
Gveric, Djordje [1 ]
Muraro, Paolo A. [1 ]
Nicholas, Richard [1 ]
Roncaroli, Federico [1 ]
Reynolds, Richard [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Ctr Neurosci, Hammersmith Hosp,Wolfson Neurosci Labs, London W12 0NN, England
[2] Swansea Univ, Coll Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales
[3] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy
基金
英国医学研究理事会;
关键词
B cells; clinical disability; grey matter lesion; microglia; neuropathology; GRAY-MATTER ATROPHY; CORTICAL DEMYELINATION; CEREBRAL-CORTEX; NEURONAL LOSS; DISABILITY; DISEASE; LESIONS; NEURODEGENERATION; INJURY; AGE;
D O I
10.1093/brain/aws189
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The primary progressive form of multiple sclerosis is characterized by accrual of neurological dysfunction from disease onset without remission and it is still a matter of debate whether this disease course results from different pathogenetic mechanisms compared with secondary progressive multiple sclerosis. Inflammation in the leptomeninges has been identified as a key feature of secondary progressive multiple sclerosis and may contribute to the extensive cortical pathology that accompanies progressive disease. Our aim was to investigate the extent of perivascular and meningeal inflammation in primary progressive multiple sclerosis in order to understand their contribution to the pathogenetic mechanisms associated with cortical pathology. A comprehensive immunohistochemical analysis was performed on post-mortem brain tissue from 26 cases with primary progressive multiple sclerosis. A variable extent of meningeal immune cell infiltration was detected and more extensive demyelination and neurite loss in the cortical grey matter was found in cases exhibiting an increased level of meningeal inflammation. However, no tertiary lymphoid-like structures were found. Profound microglial activation and reduction in neuronal density was observed in both the lesions and normal appearing grey matter compared with control cortex. Furthermore, cases with primary progressive multiple sclerosis with extensive meningeal immune cell infiltration exhibited a more severe clinical course, including a shorter disease duration and younger age at death. Our data suggest that generalized diffuse meningeal inflammation and the associated inflammatory milieu in the subarachnoid compartment plays a role in the pathogenesis of cortical grey matter lesions and an increased rate of clinical progression in primary progressive multiple sclerosis.
引用
收藏
页码:2925 / 2937
页数:13
相关论文
共 50 条
  • [41] Cell and molecular changes in the grey matter of secondary progressive multiple sclerosis cases in response to meningeal inflammation
    Magliozzi, R.
    Howell, O. W.
    Durrenberger, P. F.
    Nicholas, R.
    Roncaroli, F.
    Aloisi, F.
    Reynolds, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S174 - S174
  • [42] Intrathecal Inflammation in Progressive Multiple Sclerosis
    Monaco, Salvatore
    Nicholas, Richard
    Reynolds, Richard
    Magliozzi, Roberta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 11
  • [43] Compartmental inflammation in progressive multiple sclerosis
    Chomyk, A.
    Cyncynatus, K.
    Trapp, B. D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 54 - 55
  • [44] Meningeal inflammation in multiple sclerosis The key to the origin of cortical lesions?
    Mainero, Caterina
    Louapre, Celine
    NEUROLOGY, 2015, 85 (01) : 12 - 13
  • [45] Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis
    Kooi, Evert-Jan
    Geurts, Jeroen J. G.
    van Horssen, Jack
    Bo, Lars
    van der Valk, Paul
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (09): : 1021 - 1028
  • [46] The lymphocyte subpopulation in patients with primary progressive multiple sclerosis and secondary progressive multiple sclerosis
    Belniak, Ewa
    Bojarska-Junak, Agnieszka
    Bartosik-Psujek, Halina
    Mitosek-Szewezyk, Krystyna
    Kulka, Malgorzata
    Stelmasiak, Zbigniew
    Rolinski, Jacek
    MULTIPLE SCLEROSIS, 2008, 14 : S116 - S116
  • [47] In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis
    Rovaris, M
    Bozzali, M
    Santuccio, G
    Ghezzi, A
    Caputo, D
    Montanari, E
    Bertolotto, A
    Bergamaschi, R
    Capra, R
    Mancardi, G
    Martinelli, V
    Comi, G
    Filippi, M
    BRAIN, 2001, 124 : 2540 - 2549
  • [48] Hydroxychloroquine for Primary Progressive Multiple Sclerosis
    Koch, Marcus W.
    Kaur, Sharanjit
    Sage, Kayla
    Kim, Janet
    Levesque-Roy, Myriam
    Cerchiaro, Graziela
    Yong, Voon Wee
    Cutter, Gary R.
    Metz, Luanne M.
    ANNALS OF NEUROLOGY, 2021, 90 (06) : 940 - 948
  • [49] Diagnosis of primary progressive multiple sclerosis
    Montalban, X
    NEUROLOGICAL SCIENCES, 2004, 25 : S31 - S31
  • [50] Treatment of Primary Progressive Multiple Sclerosis
    Kantarci, Orhun
    SEMINARS IN NEUROLOGY, 2013, 33 (01) : 74 - 77